145 related articles for article (PubMed ID: 38267862)
1. Role of microRNA-4739 in enhancing cisplatin chemosensitivity by negative regulation of RHBDD2 in human cervical cancer cells.
Li Y; Zhou Z; Qu J; Gong P; Wei Y; Sun Y
Cell Mol Biol Lett; 2024 Jan; 29(1):20. PubMed ID: 38267862
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of
Tian J; Li Z; Jiang Y; Gu W; Kong E; Hao Q; Kong B; Sun L
Rejuvenation Res; 2022 Oct; 25(5):243-252. PubMed ID: 36039935
[TBL] [Abstract][Full Text] [Related]
3. CircRNA circ_0005273 contributes to the cisplatin resistance of cervical cancer cells by sponging miR-133b.
Wu L; Gao J; Liu S; Jia Y; Li C; Duan L
J Obstet Gynaecol; 2022 Oct; 42(7):3086-3093. PubMed ID: 35861544
[TBL] [Abstract][Full Text] [Related]
4. LncRNA NNT-AS1 contributes to the cisplatin resistance of cervical cancer through NNT-AS1/miR-186/HMGB1 axis.
Liu Y; Guo R; Qiao Y; Han L; Liu M
Cancer Cell Int; 2020; 20():190. PubMed ID: 32489326
[TBL] [Abstract][Full Text] [Related]
5. miR-34b-3p-mediated regulation of STC2 and FN1 enhances chemosensitivity and inhibits proliferation in cervical cancer.
Jin S; Wang W; Xu X; Yu Z; Feng Z; Xie J; Lv H
Acta Biochim Biophys Sin (Shanghai); 2024 May; 56(5):740-752. PubMed ID: 38477044
[TBL] [Abstract][Full Text] [Related]
6. Exosome-delivered circRNA circSYT15 contributes to cisplatin resistance in cervical cancer cells through the miR-503-5p/RSF1 axis.
Chen Z; Xu Z; Wang Q; Wang L; Zhang H; Wang W; Zhao H; Guo Y; Cui J
Cell Cycle; 2023 Oct; 22(20):2211-2228. PubMed ID: 37974391
[TBL] [Abstract][Full Text] [Related]
7. [EBF1 Promotes the Sensitivity of Cervical Cancer Cells to Cisplatin via Activating FBN1 Transcription].
Shen NN; Lin JH; Liu PP
Mol Biol (Mosk); 2023; 57(3):503-504. PubMed ID: 37326054
[TBL] [Abstract][Full Text] [Related]
8. LncRNA MEG3 promotes cisplatin sensitivity of cervical cancer cells by regulating the miR-21/PTEN axis.
Du Y; Geng G; Zhao C; Gao T; Wei B
BMC Cancer; 2022 Nov; 22(1):1145. PubMed ID: 36344947
[TBL] [Abstract][Full Text] [Related]
9. TMEM45A Affects Proliferation, Apoptosis, Epithelial-Mesenchymal Transition, Migration, Invasion and Cisplatin Resistance of HPV-Positive Cervical Cancer Cell Lines.
Liu Y; Liu L; Mou ZX
Biochem Genet; 2022 Feb; 60(1):173-190. PubMed ID: 34143331
[TBL] [Abstract][Full Text] [Related]
10. miR-96-5p regulates cervical cancer cell resistance to cisplatin by inhibiting lncRNA TRIM52-AS1 and promoting IGF2BP2.
Wu EY; Huang LP; Bao JH
Kaohsiung J Med Sci; 2022 Dec; 38(12):1178-1189. PubMed ID: 36354205
[TBL] [Abstract][Full Text] [Related]
11. Long Noncoding RNA Brain Cytoplasmic RNA 1 Induces Cisplatin-Resistance of Cervical Cancer Cells by Sponging MicroRNA-330-5p and Upregulating High-Mobility Group Box 3.
Sun D; Cao R; Han L; Yu X; Wang H; Wang X; Chen X
Gynecol Obstet Invest; 2022; 87(3-4):200-210. PubMed ID: 35705019
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin resistance and malignant behaviors of lung cancer cells are promoted by circ_0002360 via targeting miR-6751-3p to regulate the expression of ZNF300.
Ding L; Li L; Tang Z
Thorac Cancer; 2022 Apr; 13(7):986-996. PubMed ID: 35166026
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-125a-5p targets LIM kinase 1 to inhibit cisplatin resistance of cervical cancer cells.
Xu Y; Zheng Y; Duan Y; Ma L; Nan P
Oncol Lett; 2021 May; 21(5):392. PubMed ID: 33777215
[TBL] [Abstract][Full Text] [Related]
14. linc00958/miR-185-5p/RSF-1 modulates cisplatin resistance and angiogenesis through AKT1/GSK3β/VEGFA pathway in cervical cancer.
Tian J; Cheng L; Kong E; Gu W; Jiang Y; Hao Q; Kong B; Sun L
Reprod Biol Endocrinol; 2022 Sep; 20(1):132. PubMed ID: 36056431
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of Long Noncoding RNA (lncRNA) X-Inactive Specific Transcript (XIST) is Associated with Cisplatin Resistance in Non-Small Cell Lung Cancer (NSCLC) by Downregulating MicroRNA-144-3p.
Tian LJ; Wu YP; Wang D; Zhou ZH; Xue SB; Zhang DY; Wei YG; Liu W
Med Sci Monit; 2019 Oct; 25():8095-8104. PubMed ID: 31659146
[TBL] [Abstract][Full Text] [Related]
16. MiR-200c-3p and miR-485-5p overexpression elevates cisplatin sensitivity and suppresses the malignant phenotypes of non-small cell lung cancer cells through targeting RRM2.
Liu Y; Zhang Y; Li Q; Xu R; Huang N
Thorac Cancer; 2022 Jul; 13(13):1974-1985. PubMed ID: 35599447
[TBL] [Abstract][Full Text] [Related]
17. MiR-181a Promotes Apoptosis and Reduces Cisplatin Resistance by Inhibiting Osteopontin in Cervical Cancer Cells.
Xu X; Jiang X; Chen L; Zhao Y; Huang Z; Zhou H; Shi M
Cancer Biother Radiopharm; 2019 Nov; 34(9):559-565. PubMed ID: 31436472
[No Abstract] [Full Text] [Related]
18. Circ_0020123 enhances the cisplatin resistance in non-small cell lung cancer cells partly by sponging miR-140-3p to regulate homeobox B5 (HOXB5).
Wei D; Zeng J; Rong F; Xu Y; Wei R; Zou C
Bioengineered; 2022 Mar; 13(3):5126-5140. PubMed ID: 35170372
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-7-5p Promotes Cisplatin Resistance of Cervical Cancer Cells and Modulation of Cellular Energy Homeostasis by Regulating the Expression of the PARP-1 and BCL2 Genes.
Yang F; Guo L; Cao Y; Li S; Li J; Liu M
Med Sci Monit; 2018 Sep; 24():6506-6516. PubMed ID: 30219819
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of Linc00173 increases BCL2 mRNA stability via the miR-1275/PROCA1/ZFP36L2 axis and induces acquired cisplatin resistance of lung adenocarcinoma.
Tao X; Li Y; Fan S; Wu L; Xin J; Su Y; Xian X; Huang Y; Huang R; Fang W; Liu Z
J Exp Clin Cancer Res; 2023 Jan; 42(1):12. PubMed ID: 36627670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
